Quantum BioPharma is trading 5.88% lower at $2.08 amid a broader risk-off session. - Biotech is down 5.19%, and major U.S. indexes are also sharply lower. - Reuters says Thursday’s market declines reflected renewed concerns about AI-related regulation and data-center construction, contributing to weakness across growth stocks. - No clear company-specific announcement was identified for November 5, 2026. The company’s Q3 earnings preview is for November 6, not a reported result today.